Background: Monoclonal free light chains (FLCs) frequently cause rapidly progressive renal failure in patients with multiple myeloma. Immunoassays which provide quantitative measurement of FLCs in ...

Researchers sought to identify prognostic factors for survival in patients with newly diagnosed multiple myeloma.

SAN DIEGO -- The risk of progression from smoldering multiple myeloma to symptomatic disease ... uninvolved free light chain ratio ≥8 and 100, and BMPCs >50% but <60%. Patients were randomized ...

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

It isn’t blood cancer in itself, but some people with MGUS will eventually develop multiple myeloma or other related blood cancers. MGUS comes in three types: IgM, non-IgM, and light chain.

A common cause of this type of cardiac amyloidosis is having a diagnosis of certain blood cancers, like multiple myeloma.

Study reveals VLCFA metabolism as a key target in multiple myeloma, enhancing drug efficacy and overcoming resistance.

We do not know what causes MGUS. There may be a link to autoimmune diseases, genetics, or environmental factors. Like multiple myeloma, MGUS starts in a type of white blood cell called plasma cells.

A stem cell transplant can be a good treatment for multiple myeloma. A successful transplant gives someone with multiple myeloma new, healthy bone marrow. It replaces the bone marrow harmed by myeloma ...

analysis of serum free light chain ratio analysis in patients with dialysis-dependent renal failure. When using an abnormal serum FLC ratio as an indication of underlying multiple myeloma ...